BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Zoonoses

Below is an extended Zoonoses patents listing. Click here to return to the Zoonoses main in depth entry.

Patents :

US Patent No.Title
4267170 Methods of using chlamydia vaccine for preventing and treating bovine diseases
5510241 Method of testing for the presence of Salmonella serotypes expressing Salmonella enteritidis fimbrial antigen (SEFA) and reagents therefore
5616689 Method of controlling structure stability of collagen fibers produced form solutions or dispersions treated with sodium hydroxide for infectious agent deactivation
5716822 Feline calicivirus capsid gene and protein
5718901 Feline calicivirus gene
5730984 Vaccine against helminth infection comprising Sm-14 fatty acid binding protein of Schistosoma mansoni
5756678 Prion inactivation in connective tissue materials
5795779 Human interferon-.beta. (IFN-.beta.) produced in Chinese hamster ovary (CHO) cells
5879719 Process for control, elimination or inhibition of salmonellae in reptiles and/or amphibians
5464625 Non-toxic methods of repelling rodents from materials susceptible to rodent consumption
5376567 Expression of interferon genes in Chinese hamster ovary cells
5202430 Transmissible gastroenteritis virus genes
4569908 Multiclass hybrid interferons
4758428 Multiclass hybrid interferons
4966843 Expression of interferon genes in Chinese hamster ovary cells
4973479 Interferon-.alpha.61
4975276 Interferon-alpha 54
5019411 Process for bacterial decontamination of vegetable foods
5098703 Interferon-alpha 76
5178857 Pharmaceutical compositions and their use in the treatment of parasitoses
6039684 Non-lethal conditioning methods for the treatment of acquired immunodeficiency syndrome
6191168 Methods for the use of nonprotein amino acids as therapeutic agents
6444445 Live vaccine against Brucellosis
7128916 Bacteriophage-mediated immunisation
7148323 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
7235232 Interferon alpha hybrids
7311904 Tissue matrices comprising placental stem cells, and methods of making the same
7364745 Development of a live, attenuated, recombinant vaccine for Brucellosis
7390626 Methods and kit for diagnosing tick borne illnesses
7404969 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7410474 Methods and means for extracorporeal organ perfusion
7101554 Picornaviruses, vaccines and diagnostic kits
7041444 Murine calicivirus
6986887 Universal stem cells
6518064 Pink bollworm expression system for commercially valuable protein production
6554188 Terminal for an active labelling system
6593080 Diagnosis, prevention and treatment of calicivirus infection in humans
6685933 Interferon .alpha. hybrids
6743899 Process for inactivating prions in lipoproteins
6825028 Recombinant listeria
6930176 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
6943239 Antigenic fusionprotein carrying Gal.alpha.1,3Gal epitopes
7427398 Mammalian animal composition

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.